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Tumor promoting phorbol esters, such as 12-0-tetradecan-
oylphorbol-13-acetate (TPA), when applied topically to 
mouse skin cause inflammation and hyperplasia. The major 
cellular phorbol ester receptor is a calcium and phospholipid 
dependent protein kinase, protein kinase C (PK-e). PK-C is 
directly activated by TPA and most of the responses of cells to 
TPA appear to be mediated by PK-C. This suggests that 
PK-C may playa key role as a mediator of inflammation and 
growth in TPA treated mouse skin. 
Sphingosine has been reported to be a potent inhibitor of 
PK-C in vitro and in intact leukocytes. We therefore have 
T opical application of phorbol esters such as 12-0-te-tradecanoylphorbol-13-acetate, causes characteristic epidermal alterations, the most prominent of which are accelerated terminal differentiation, inflamma-tion, and hyperplas ia [1-3]. A calcium/phospholipid-
dependent protein kinase, C (PK-C) , is the major cellular phorbol 
est~r receptor. I~ the presence of phosphatidyls.eiine and physio-
logiC concentratIOns of calcIUm, phorbol esters bllld to and activate 
protein kinase C [4]. Phorbol esters mimic the physiologic activator 
of protein kinase C, snl ,2-diacylglycerol (DAG) [5], which is 
formed by the hydrol ysis of cell membrane phospholipids by the 
enzyme phospholipase C (for review, see Ref 6). 
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investigated the effects of sphingosine upon TPA-induced 
inflammation, hyperplasia, induction of ornithine decarbox-
ylase (ODe) activity and ODC mRNA, and activation of 
PK-C in mouse skin. 
The results demonstrate that sphingosine is a potent inhib-
itor of all of the TPA-induced responses examined. These 
data are compatible with the hypothesis that PK-C is a major 
mediator of the phorbol ester response in mous() skin. Fur-
thermore, PK-C inhibitors may have therapeutic potential in 
inflammatory skin diseases such as psoriasis.] Invest Derrnatol 
91:486-491, 1988 
The relationship between protein kinase C and the pleotypic 
effects caused by phorbol esters has been systematically examined in 
a large number of cell types, including keratinocytes [7] (for review, 
see Refs 8,9). These studies demonstrate that, in most cases, the 
effects of phorbol ester on cell fun ction are unequivocally mediated 
by protein kinase C. Thus it would appear that protein kinase C 
occupies a pivotal role in the regul ation of epidermal growth and 
differentiation. 
It has recently been demonstrated that sphingosine (a natural 
product of lipid metabolism) is a potent and reversible inhibitor of 
PK-C activity in vitro and of TPA-induced activation of human 
platelets and leukocytes [10 -12]. W e were therefore interested in 
determining whether topical sphingosine could inhibit the inflam-
matory hyperplas tic response of mouse skin to TPA. To address this, 
we evaluated the clinical, histo logic, and biochemical (ODC activ-
ity, ODC mRNA level, and PK-C activity) responses of mouse skin 
foll owing application ofTPA alone or in conjunction with sphin-
gosine. In this report we demonstrate that spingosine is an effective 
inhibitor of all of the above-mentioned TPA-induced respo nses in 
mouse epidermis. 
MATERIALS AND METHODS 
Materials TPA, sphingosine, EDTA, EGTA, and salmon sperm 
DNA were purchased from Sigma Chemical Company (St. Louis, 
Missouri) . (L- I- 14C)ornithine (51.3mC ijmmol) was obtained from 
N ew England Nuclear (Boston, MA). (32P)deoxycytidine triphos-
phate was from ICN Radiochemicals (Irvine, California). DEAE 
ce llulose (DE 52) was obtained from Whatman (Hilsboro, Ore-
gon) . Phosphatidylserine was purchased from Avanti Polar Lipids 
(Birmingham, Alabama). Yeast t-RNA was from Boehringer-Man-
heim (Indianapolis, Indiana). Dextran sulphate was obtained from 
Pharmacia (Pi scataway, N ew J ersey). All the other chemicals were 
of at least reagent grade. Plasmids pOD48 and pGAD28 were gen-
erously provided by D r. Phillip CoRino, University of California, 
0022-202Xj88jS03.50 Copyright © 1988 by The Society for Investigativc Dermatology, Inc. 
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San Francisco, and Dr. Acj1illes Dugaiczyk, Baylor University, re-
spectivel y. 
Animals and Treatment Hairless mice (strain HRS/J, Jackson 
Laboratories, Bar Harbor. Maine) , 8 weeks of age, were used. TPA 
was dissolved in acetone and sphingosine in ethanol. The hairless 
mice were treated with acetone, ethanol, TPA, and sphingosine at 
the doses and times indicated in the text by depositing the dissolved 
agents carefully over a 4 cm2 area of the back with microliter pi-
pette. 
Histology Acetone, TPA (10 nmol) alone or followed immedi-
ately by the application of sphingosine (20 ,umol) were applied to 
the backs of hairless mice. The mice were killed at day 1 or 3 
following a single treatment of one of the above, and 4-mm punch 
biopsies were taken. Paraffin tissue sections were stained with H & E 
(days 1 and 3) and quantitative morphometric measurements of 
epidermal thickness of epidermis were made (day 3 only) using a 
computer assisted digitized morphometric analyser (Bioquant, 
IBM, Nashville, TN). At least 15 measurements were made on 
representaive sections from several skin biopsies. 
Assay ofODC Activity Mice were killed 5h after a single appli-
cation of either acetone, TPA (10 nmol) alone or TPA (10 I1mol) 
plus sphingosine (2.5-20 ,umol). The treated skin on the dorsum of 
the mice was keratomed to a depth of 0.1 mm. After removel , the 
skin was snap-frozen in liquid nitrogen. The tissue was crushed and 
homogenized in a glass homogenizer in 2 ml of assay buffer con-
taining 50 mM HEPES (pH 7.1), 5 mM OTT, 0.5 mM pyridoxal 
phosphate, and 0.1 mM EDT A. The homogenate was then centri-
fuged at 100,000 X g for 30 min. An aliquot (0.2 ml) of the superna-
tant was assayed for ODC activity as previously described [13 , 14] . 
All assays were performed in duplicate. 
Protein Kinase C Activity The hairless mice were treated with 
acetone, TPA alone or TPA plus sphingosine for 30 min, killed, a.nd 
keratomed. Tissue was homogenized in 250 mM sucrose, 20 mM 
Tris, 10 mM EGTA, 2 mM EDTA, 50 mM mercaptoethanol , 
0.01 % leupeptin, and 0.01 % PMSF, pH7.5. The homogenate was 
centrifuged for 60 min at 100,000 X g. The supernatant was then 
decanted and membrane associated activity solubilized in homo-
genizing buffer containing 1 % triton X-100. After 60 min on ice, 
the membranes were centrifuged as described above. Cytosolic and 
soluble membrane PK-C were partially purified by a small column 
(1 ml) of DEAE cellulose. Protein kinase C activity was assayed by 
measuring the incorporation oP2Pi from 32P_ATP into histones as 
described [4]. All assays were performed in duplicate. 
Northern Blot Analysis ofODC mRNA RNA was isolated by 
the technique of Chirgwin et al [15] from mouse skin keratome 
biopsy fragments snap-frozen in liquid nitrogen. Biopsies were ob-
tained 5h after treatment with acetone, TPA, or TPA plus sphingo-
sine. Briefly, the frozen tissue fragments were homogenized in a 
buffer containing 4 M guanidinium isothiocyanate, centrifuged at 
400 X g remove insoluble debris, and layered over a cushion of 5.7 
M cesium chloride. After overnight centrifugation at 100,000 X g 
at 20°C, the RNA pellet was coll ected as described [16]. RNA 
concentrations were determined spectrophotometrically by mea-
suring absorbance at 26011m using the relationship 1 00260 unit = 
20 mg/ml RNA. 
Equal quantities of total RNA from each treatment group were 
subjected to electrophoresis in forma ldehyde-containing 1.2% 
agarose gels as described [16] . RNA was transferred to derivatized 
nylon membranes (Zeta-Probe, Bio-Rad, Richm.ond , CA), in lOX 
SSC (lX SSC = 0.15 M NaCI , 15 mM sod ium citrate) without 
alkali pretreatment. Pre-hybridizations were carried out at 42 °C in 
50% formamide, 5X SSC, 50 mM sodium phosphate pH7.0, 1X 
Denhardt's solution [17] , 250 J.lgjml yeast tRNA, 100 J.lgjml soni-
cated denatured sa lmon sperm DNA, and 1 % sodium dodecylsu l-
fate . Hybridizations to (32P}-labeled probes were performed for 
18-24 h at 42°C in the same buffer containing 10% dextran su lfate. 
Radiolabeled probes were prepared by the random priming method 
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[1 8] using (alpha_32P) dCTP. Agarose gel-purified fragments de-
rived by restriction endonuclease digestion of plasmids pOD48 [19] 
and pGAD28 [20] served to detect ODC and glyceraldehyde-3-
phosphate dehydrogenase mRNAs, respectively. 
Autoradiographic exposures of these blots were quantitated using 
LKB Model 2202 densitometer coupled to a Hewlett-Packard 
3390A automaic integrator. Only exposures that gave a linear re-
sponse of integrated autoradiographic intensity to the micrograms 
total RNA loaded were used . 
Data Analysis Differences in epidermal thickness between con-
trol , TPA, and TPA plus sphingosi ne treated mice were analyzed by 
a paired t test. Differences in group means in ODC and PKC activi-
ties in animals treated with TP A versus TP A and sphingosine were 
ana lyzed by the two-sample t test. 
RESULTS 
Inhibition ofTPA-Induced Inflammation by Sphingosine A 
single application of 10 nmol ofTPA to the backs of mice resulted in 
erythema and edema that was most pronounced at days 1-2. This 
response gradually subsided over the next several days. Visual in-
spection indicated that these TPA-induced changes were com-
pletely inhibited by concurrent application of sphingosine (20 
,umoljmouse). 
Biopsies of mouse skin were obtained 1 d after a single topical 
application of acetone or TPA (10 nmol in acetone). Compared to 
acetone (Fig lA), treatment with TPA resulted in an intense inflam-
matory infiltrate throughout the skin with marked collections of 
neutrophils w ithin the epidermis and with particular accumulation 
in the pilosebaceous units (Fig 1B). Although on visual inspection 
the mice appear to be hairless, histologic sections reveal the presence 
of primitive hair follicles in the dermis . N eutrophils within the 
epidermis were primarily present in the lower and mid levels, and 
while there were some areas of focal thinning of the epidermis, no 
ulceration was observed. Within the upper, mid, and deep dermis, 
neutrophils w.ere scattered primarily as single cells around blood 
vessels, although focal collections were seen, particularly in the 
deeper dermis. There was marked dermal edema with dilated vascu-
lar and lymphatic spaces and a mild perivascular mononuclear infil-
trate of lymphocytes and monocytes. Plasma cells and eosinophils 
were not identified. The underlyin3 skeletal muscle appeared essen-
tially .uninvolved by the inflammatory reaction. 
In the animals that received sphingosine and TPA, there were 
on ly rare inflammatory cells within the epidermis, but a slight peri-
vascular neutrophilic inflammatory infiltrate was observed with 
much less edema and telangiectasia (Fig le). Also, the piloseba-
ceous units remained essentiall y free of any inflammatory reaction. 
Application of sphingosine alone caused no significant changes 
compared to the acetone (data not shown). 
On day 3, following a single application of the aforementioned 
materials, the epidermis in the TP A-treated mice was markedly 
hyperpl astic (Fig 1E). Compared to the acetone control group (Fig 
1 D) , the number of cell layers in the epidermis increased from three 
to four cel l layers up to nine to 10 cell layers after TPA treatment. 
Also, the granular cell layer was much more prominent after TPA 
exposure with a more compact and thicker stratum corneum. The 
fo.l licul ar epithelium also appeared hyperplastic. There were mark-
ed ly dimished collections of neutrophils, lymphocytes, and mono-
nuclear cell s in the dermal infiltrate and the degree of edema was 
considerably less on day 3 compared to day 1. On day 3, in animals 
receiving sphingosine and TPA (Fig IF), the epidermis was thicker 
than the acetone control with four to five cell layers, but was mark-
ed ly thinner than the group treated with TPA alone . There were 
occasional neutrophils observed in the deeper dermis in the TPA 
plus sphingosine treated animals. The above data indicate that 
sphingosine inhibits TPA-induced in.flammation and epidermal hy-
perplasia. 
Quantitative morphometric analysis revealed that epidermal 
thickness had increased by 77% on the third day following TP A 
treatment (p < 0.01) (Table I) . This epidermal hyperplasia induced 
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Figure 1. Inhibition of TPA-induced leukocyte infiltration in mouse epidermis by sphingosine. A: Day 1, acetone control B: Day 1, TPA; intense 
inflammatory infiltrate throughout the skin. C: Day 1, TPA plus sphingosine; reduction in inflammatory infiltrate compared to TPA alone with only rare 
nelltrophils in the epidermis. D: Day 3, acetone control. E: Day 3, TPA; epidermis is markedly hyperplastic compared to the acetone control group. F: Day 3, 
TPA plus sphingosine; epidermis is on ly slightly thicker chan the acetone control but significantly thinner than the TPA treated group. All photographs are 
X 80 original magnification. 
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Table I. Inhibition ofTPA-lnduced Increase 
in Epidermal Thickness by Sphingosine' 
Treatment 
Day 3" (,um) 
Acetone 
TPA (lOnmol) 
TPA (10nmol) + 
Sphingosine (20 ,umol) 
Epidermal thickness 
(11m) 
28.8 ± 6.7 
51.1±4.1c 
37.8±3.1 d 
• Animals were treated with acetone, TPA, and TPA plus 
sphi ngosine as described in "Materials and methods." On day 
3 fo ll owing a single treatment, animals were killed, and punch 
biopsies were obtained and stained with H&E Epid~n~la l 
thickness was determined usi ng a computer assISted dIgItal 
morphometric analyser. . 
10 Results presented as means ± S.E. frolll 15 rcprcscntatlvc 
high power fields. 
c TPA vs acetone p < 0.0l. 
"TPA vs TPA + sphingosine p < 0.01. 
by TPA was significantly reduced (p < 0.01 )when sphingosine was 
applied concurrently with TPA. 
Inhibition ofTPA-Induced ODC Activity and IDRNA Accu-
mulation by Sphingosine It is well-doc~mented that ~opical 
application ofTPA induces polyal~ine sY I~thesls as a r~sult of md~c­
tion of ODC activity [14]. TIllS 111ductIOn IS assocIated with 1\1-
creased levels of mRNA and immunoreactive protein specific for 
ODC which is maximal 5 h after TPA treatment [21- 23]. There-
fore, ~e investigated the effects of varying doses of sphingosine on 
the induction by TPA of ODC activity and ODC mR~~. 
TPA (10 nmol) caused marked induction of ODC actlVlty, mea-
sured 5 h after applicat ion of TPA. Sphingosine, at doses varymg 
from 2.5-20 J1mol, caused a dose-dependent inhibition of TPA-
induced ODC activation (Fig 2). At the hi gher doses (15 - 20 J1molj 
mouse), ODC induction by TPA was inhibited by approximately 
75%. 
The inhibition ofTPA-inducedODC production by sphingosine 
was time dependent (Fig 3). Concurrent administration ~fT~A and 
sph ingosine produced the greatest degree of ODC .111Iubltlon. 
Sphingosine could be added up to 5 m111 after appilcatlOI? of TPA 
without dimunition of inhibition (data not shown). Appltcatlon of 
sphingosine at times greater than 2 h after application of TPA had 
little inhibitory effect. . . 
Figure 4 shows the results of Norther~ blott111g expenments 
comparing equal quantities of total RNA Isolated from mice 5 h 
after treatment with acetone vehicle, TPA alone, or wIth TPA 111 
combination with 10 or 20 J1mol of sphingosine. The same blot was 
hybridized with the pOD48 probe, which detects the 2. ~ kb ODC 
mRNA (Fig 4a, left panel) and the pGAD28 probe, wh.lch detects 
the 1.3 kb glyceraldehyde-3-phosphate GAD mRNA (Fig 4a, nght 
panel) [20] . The GAD gene was selected as a reference gene because 
the abundance of its mRNA appears to be regulated at the post-tran-
scriptionallevel in rodent tissues [24] and because prelilninary. re-
sults indicated that levels of this transcript appeared to be 111vanant 
under our experimental conditions. . . .. . 
Sphingosine caused a dose dependent.mh:b.ltlon ofTPA-111duced 
ODC mRNA (Fig 4b). The degree of 1111ubitIOn of TPA-111duced 
ODC mRNA was somewhat less (about 45% with 20 J1mol sphin-
gosine) than that observed for TPA-induced ODC activity (75°~0 
with 20 J1mol sphin gosine, Fig 2). N either TPA alone nor 111 combi-
nation with sphingosine had any significant effect on the level of 
GAD mRNA. 
The apparent existence of two hybridizing bands of ODC RNA 
is probably due to interruption of a single diffu.se band .by th.e 18S 
ribosomal RNA, which is known to interfere WIth hybndlzatlon of 
comigrating RNA on Northern blots. The cause for the ~r.oadness 
of the ODe mRNA band is not known. It IS unltkely that It IS due to 
RNA degradation during the sample processing, because the ODC 
and GAD mRNA are processed simultaneously and no RNA break-
down is seen for the glyceraldehyde-3-phosphate dehydrogenase 
RNA (Fig 4a, ri ght panel) . 
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Figure 2. Sphingosine dependence for inhibition of TPA induced. ODe 
activity. TPA (10 nmol) was either applied alone or together WIth the 
indicated amounts of sph ingosine to the backs of mIce. ~acl~ value IS the 
mean of duplicate determinations from each of 6 mIce. Bars indIcate standard 
error (S.E.). ' p < 0.05 compared to TPA alone. 
Inhibition of TPA-Induced Down Regulation of PK-C by 
Sphingosine Evidence suggests that induction of ODC a~tivity 
by TPA is mediated by PK-C [22]. TPA causes translocation of 
PK-C from the cytosol to the cell membrane, where it is transiently 
activated and subsequently down regulated. We therefore ex~m­
ined the effect of sphingosine on TPA-induced down regulation. 
Following treatment with TPA for 30 min, there was a marke.d 
decrease in both the s91uble and membrane assOCiated PK-C actIvI-
ties, compared with control (Fig 5). In contrast, there ~as a modest 
increase in soluble PK-C activity in anima ls treated WIth TPA plus 
sphingosine compared to controls. Altho~gh the membr~ne-as~o­
ciated PK-C activity in animals treated With TPA and sphmgosme 
was approximately one-half of that in controls, it was 2.3 times 
greater than in animals treated with TPA alone. These data d~mon­
strate that sph ingosine inhibits TPA-ll1duced down regulation of 
PK-C activity. 
DISCUSSION 
The data presented demonstrate that sphingosine is a potent il~hibi­
tor of the TP A-induced inflammatory hyperplastic response 111 the 
skin of hai rless mice. Sphingosine greatly diminished the dermal 
leukocyte infiltrate that occurred 1 d afterTPA treatment, and sIg-
nificantly inhibited the epidermal hyperplasi.a that o.ccurred on day 
3. In additon, sphingosine inhibited three bIOchemical paran~eters 
associated with the TPA-induced inflammatory hyperplastIc re-
sponse; induction of ODC activity, increase in ODC message level, 
and down regu lation of PK-C. .. . 
The histologic alterations induced by TPA 111 haIrless mouse sk111 
were similar to those reported in other strams of mice [3] . The 
epidermal thickness of the hairless mouse increased from 29to 51 
ILm, 3 dafter TPA treatment. Comparable values have been reported 
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Figure 3. Effect of time of application of sphingosine on inhibition ofTPA 
induced ODe activiry. TPA (10 nmolm 0.1 ml acetone) wasap~lIed at tIme 
t = 0 and sphingosine (20 ttmol/mouse) was apP.lIed at the ll~dlc~ted tllnes 
fo llowing TPA. Each value is the mean of duphcatc deternunattons from 
each of six mice. Bars indicate S.E.' p < 0.05 compared to TPA alone. 
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Figure 4. E/fects of TPA and sphingosine treatment on ODC and GAD 
mRNA levels in hairless mouse epidermis A: Northern blots of total RNA 
(20 lig) isolated fro m keratomes of hairless mouse skin 5 h after treatment 
with: 1) ace tone, 2) TPA (10nmol) in acetone, 3) TPA (10nmol) plus sphin-
gos1l1e (10limol) at t = 0, or 4) TPA (10nmol) plus sphingosine (20 limol) at 
t = O. A, Left pallei: OD48 (ODe) probe. Right palle!: after OD48 probe was 
stripped by boiling; the same blot was hybridized with the pGAD28 (GAD) 
probe. B: The blot shown in A and a duplicate blot run in parallel were 
hybridized against the OD48 probe (striped bars), then stripped and hybrid-
ized against the GAD28 probe (opw bars). Autoradiograms that showed a 
linear response to RNA loading were analyzed by quantitative densitometry. 
Results arc expressed in terms of fo ld change relative to acetone control. The 
average and range of values arc shown. 
for control and TPA-treated Sencar mice (25] . It is well documented 
that TPA induces epidermal DNA synthesis (26,27] and that this is 
refl ected in increased epidermal thickness (25]. On day 3, the gran-
ular cell layer in the epidermis ofTPA-treated mice was much more 
prominent than in control epidermis. This has also been observed by 
others, and suggests that TPA alters the normal program for epider-
mal cell differentiation [2,3,25]. 
The major cellular phorbol ester receptor is PK-C. Protein kinase 
C is directly activated by phorbol esters, and many , if not all, of the 
pleotypic responses induced by phorbol esters are belived to be me-
diated by PK-e. Activation of PK-C by TPA initiates a cascade of 
biochemical reactions that eventuate in a cellular response such as 
secretion, growth, or differentiation. Activation of PK-C by phor-
bol esters is associated with translocation of the enzyme from the 
cytosol, where it exists in an inactive state, to the membrane. Fol-
lowing its activation by association with membrane phospholipid, 
phorbol ester, and calcium, the enzyme is subsequently down regu-
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Figure 5. Inhibition ofTPA-induced down-regulation of PK-C by sphin-
gosine. Mice were treated with TPA (10 nmol) alone or together with 
sphingosine (17 ).lmol/mouse) for 30 min. Control mice were treated with 
ethanol/acetone (1 :1). (II: soluble PK-C activity, ll!lI: membrane associated 
PK-C activity). Each value is the mean of duplicate determinations from 
each of 4 animals. Bars indicate S.E." p < 0.05 compared to control. 
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lated [28 - 30]. Activated PK-C l!as increased susceptibility to degra_ 
datIOn by a neutral ca!clUm actlv~ted proteas~ [3 ~] . Evidence sug_ 
gests th at the ?ecrease 111 PK-C actiVity follow1l1g Its activation (i.e. , 
down regulation) results from proteolytic degradation. Thus activa-
tion of PK-C by phorbol ester causes rapid loss of cytosolic activity 
due to translocation to the membrance and subsequent decrease in 
me~nbrane-associated activity (down regulation), due to proteolysis. 
Thirty minutes after application of TPA both soluble and mem-
brane associated PK-C activity in mouse epidermis were signifi-
can~ly decreased, presumably as a result of down regulation. Sphin-
gosme blocked tillS decrease, suggesting that it inhibited membrane 
translocation and activation of PK-C by TPA. There was, in fact, a 
modest, albeit significant, increase in soluble associated PK-C activ-
ity following treatment with TPA plus sphingosine. This increase 
may have been due to displacement of PK-C from the membrane 
associated fraction to the so luble fraction by sphingosine. This dis-
placement may have contributed to the decrease in membrane asso-
ciated PK-C activitJ: observed with TPA plus sphingosine, although 
some down regulatIOn of membrane associated activity cannot be 
ruled out. Grove and Mastro have recently reported inhibition of 
TPA-induced PK-C down-regulation by sphingosine in lympho-
cytes (32] . This is consistent with the proposed mechanism of 
sphing.osi l!e. inhibi~ion of PK-C, whereby sphingosine competi-
tively II1hlblts the II1teractlon of phospholipid, Ca++ 'and TPA or 
DAG with the enzyme, and thus prevents the formation of an active 
lipid-enzyme complex [10] . Sphingosine also blocked TPA-in-
duced inflammation and epidermal hyperplasia as assessed histolog-
ically and biochemically. Because these later responses antecede 
P~-C ~ctivation, the data are consistent with the hypothesis that 
activation of PK-C is a key event in the TPA-induced hyperplastic 
inflammatory response in mouse skin. 
. Maximum inhibition ofTPA-induced ODC activity by sphingo-
sine was observed at 20,umol/mouse. On a mole basis, this repre-
sents a 2,OOO-fold excess of sphingo~ine compared to TPA. A similar 
excess of sphingosine was required for inhibition of phorbol ester 
bin.din~ to intact platelets [10] and for inhibition of phorbol ester 
activation of pun~ed .PK-C il1 vitro [10]. Thus the amount of sphin-
gos1l1e needed to II1111blt the TPA-induced responses in mouse skin 
is consistent with the relative affinities ofTPA and sphingosine for 
interaction with PK-C. 
Inhibition of TPA-induced ODC activity by sphingosine was 
time dependent (Fig 3). Application of sphingosine at times greater 
than 2 h after TPA did not inhibit induction of ODe. Maximal 
il?hibition was observed with simultaneous application of sphingo-
sll1e and TPA. As the time interval berween application of TPA 
followed by sphingosine increased, the inhibitory effect on ODC 
activity was reduced. These data are consistent with sphingosine 
inhibiting an early response to TPA. 
It has been reported that sphinganine (dihydrosphingosine) 
blo~ks the TPA-lI1duced oxidative burst in human neutrophils [11]. 
TIllS was attributed to the abi lity of sphinganine to inhibit the 
activation of PK-C by TP A. It has recently been suggested, how-
ever, that the effects of sphinganine on neutrophil activation reflect 
non-specific cell damage rather than specific inhibition of PK-C 
[33]. However, we found that at the doses used in this study, sphin-
gosll1e alone caused no histologically detectable epidermal damage. 
In addition, the hnding the sphingosine added 2 h after TPA did not 
inhibit induction of ODC activity argues against the inhibitory 
effects of sphingosine being due to cytotoxicity. 
Two groups have shown that topical treatment of rodent skin 
with TPA results in increases in steady state ODC mRNA levels 
with a time course comparable to the induction of ODC activity 
[22,23]. W e found a similar induction of ODC mRNA and that this 
induction was inhibited by sphingosine in a dose-dependent man-
ner. Whether TP A treatment results in increased transcription of 
the ODe gene or increased stability of the ODe message in this 
system is no t known. It is of interest that, although ODC activity is 
negligible in untreated mOllse epidermis, the ODe mRNA is read-
ily detectabl e. This may refl ect the regulation of ODC activity in 
mouse epidermis at both the pre- and post-transcriptional levels, as 
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has been reported in muri.ne lymphocytes [34] and fibroblasts [35] . 
Sphingomyelin and ceramides are normal constituents of human 
epidermal cells [36] . Because sphingosine is a metabolite of these 
compounds, it is also likely to be present in human epidermis . In the 
present study, sphingosine was employed as a pharmacologic agent 
to inhibit the phorbol ester response in mouse sk in. It has recently 
been proposed that sphingosine may be a physiologic regulator of 
cell function via its modulation of PK-C [10,37] . In view of the 
apparent importance of PK-C in the regulation of epidermal cell 
homeostasis, inhibitors ofpK-C such as sphingosine may have some 
cl inical usefulness in the treatment of inflammatory dermatoses. 
The extent to which sphingosine participates in the regulation of 
human epidermis and its significance to the pathophysiology of 
inflammatory hyperplastic skin diseases, such as psoriasis, remains 
to be investigated. 
The skilled tech II ical assistallce oJVirgillia Harris,Jell/lifer Kowalke, alld Prashall t 
Trivedi is grateJidly ackllowledged. Ti,e auchors also grateJidly ackllowledge Jell/lifer 
Appleberry Jor typillg the //lallI/script. 
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